Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 138


[Medical errors and the apology laws, do we need them?]

Giraldo P, Castells X.

Med Clin (Barc). 2015 Jun 2. pii: S0025-7753(15)00262-6. doi: 10.1016/j.medcli.2015.04.019. [Epub ahead of print] Spanish. No abstract available.


Robustness of equations that define molecular subtypes of glioblastoma tumors based on five transcripts measured by RT-PCR.

Castells X, Acebes JJ, Majós C, Boluda S, Julià-Sapé M, Candiota AP, Ariño J, Barceló A, Arús C.

OMICS. 2015 Jan;19(1):41-51. doi: 10.1089/omi.2014.0077.


Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.

Castells X, Domingo L, Corominas JM, Torá-Rocamora I, Quintana MJ, Baré M, Vidal C, Natal C, Sánchez M, Saladié F, Ferrer J, Vernet M, Servitja S, Rodríguez-Arana A, Roman M, Espinàs JA, Sala M.

Breast Cancer Res Treat. 2015 Jan;149(1):237-44. doi: 10.1007/s10549-014-3208-z. Epub 2014 Dec 13.


Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.

Jelaković B, Castells X, Tomić K, Ardin M, Karanović S, Zavadil J.

Int J Cancer. 2015 Jun 15;136(12):2967-72. doi: 10.1002/ijc.29338. Epub 2014 Dec 10.


Work, family and social environment in patients with Fibromyalgia in Spain: an epidemiological study: EPIFFAC study.

Collado A, Gomez E, Coscolla R, Sunyol R, Solé E, Rivera J, Altarriba E, Carbonell J, Castells X.

BMC Health Serv Res. 2014 Nov 11;14:513. doi: 10.1186/s12913-014-0513-5.


Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme.

Blanch J, Sala M, Ibáñez J, Domingo L, Fernandez B, Otegi A, Barata T, Zubizarreta R, Ferrer J, Castells X, Rué M, Salas D; INCA Study Group.

PLoS One. 2014 Oct 21;9(10):e110207. doi: 10.1371/journal.pone.0110207. eCollection 2014.


Does digital mammography suppose an advance in early diagnosis? Trends in performance indicators 6 years after digitalization.

Sala M, Domingo L, Macià F, Comas M, Burón A, Castells X.

Eur Radiol. 2015 Mar;25(3):850-9. doi: 10.1007/s00330-014-3431-3. Epub 2014 Sep 26.


Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Otasowie J, Castells X, Ehimare UP, Smith CH.

Cochrane Database Syst Rev. 2014 Sep 19;9:CD006997. doi: 10.1002/14651858.CD006997.pub2. Review.


Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.

Cunill R, Castells X, Tobias A, Capellà D.

J Psychopharmacol. 2015 Jan;29(1):15-23. doi: 10.1177/0269881114544777. Epub 2014 Aug 20. Review.


The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona.

Murta-Nascimento C, Romero AI, Sala M, Lorente JA, Bellmunt J, Rodero NJ, Lloreta J, Hospital À, Burón A, Castells X, Macià F.

Eur J Cancer Prev. 2015 Jul;24(4):335-9. doi: 10.1097/CEJ.0000000000000075.


[Experience in the development of a code of best practices in healthcare].

Giraldo P, Carbonell J, Pujolar N, Burón A, Castells X.

Rev Calid Asist. 2014 Jul-Aug;29(4):250-1. doi: 10.1016/j.cali.2014.05.005. Epub 2014 Jun 28. Spanish. No abstract available.


[Development and validation of an algorithm to identify cancer recurrences from hospital data bases].

Manzanares-Laya S, Burón A, Murta-Nascimento C, Servitja S, Castells X, Macià F.

Rev Calid Asist. 2014 Jul-Aug;29(4):237-44. doi: 10.1016/j.cali.2014.05.004. Epub 2014 Jun 28. Spanish.


Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model.

Comas M, Arrospide A, Mar J, Sala M, Vilaprinyó E, Hernández C, Cots F, Martínez J, Castells X.

PLoS One. 2014 May 15;9(5):e97459. doi: 10.1371/journal.pone.0097459. eCollection 2014.


[Attention deficit hyperactivity disorder].

Cunill R, Castells X.

Med Clin (Barc). 2015 Apr 20;144(8):370-5. doi: 10.1016/j.medcli.2014.02.025. Epub 2014 Apr 29. Review. Spanish.


Reply to the letter to the editor by Ramos-Quiroga et al.

Cunill R, Castells X, Tobias A, Capellà D.

Pharmacoepidemiol Drug Saf. 2014 Apr;23(4):437-8. doi: 10.1002/pds.3570. No abstract available.


Modelling mutational landscapes of human cancers in vitro.

Olivier M, Weninger A, Ardin M, Huskova H, Castells X, Vallée MP, McKay J, Nedelko T, Muehlbauer KR, Marusawa H, Alexander J, Hazelwood L, Byrnes G, Hollstein M, Zavadil J.

Sci Rep. 2014 Mar 27;4:4482. doi: 10.1038/srep04482.


Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.

Vilaprinyo E, Forné C, Carles M, Sala M, Pla R, Castells X, Domingo L, Rue M; Interval Cancer (INCA) Study Group.

PLoS One. 2014 Feb 3;9(2):e86858. doi: 10.1371/journal.pone.0086858. eCollection 2014.


Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.

Domingo L, Salas D, Zubizarreta R, Baré M, Sarriugarte G, Barata T, Ibáñez J, Blanch J, Puig-Vives M, Fernández A, Castells X, Sala M; INCA Study Group.

Breast Cancer Res. 2014 Jan 10;16(1):R3. doi: 10.1186/bcr3595.


Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.

Román M, Rué M, Sala M, Ascunce N, Baré M, Baroja A, De la Vega M, Galcerán J, Natal C, Salas D, Sánchez-Jacob M, Zubizarreta R, Castells X; Cumulative False Positive Risk Group.

PLoS One. 2013 Dec 23;8(12):e83121. doi: 10.1371/journal.pone.0083121. eCollection 2013.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk